Vivanza Biosciences
Vivanza Biosciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Vivanza Biosciences
Start SIPVivanza Biosciences Investment Rating
-
Master Rating:
-
Vivanza Biosciences has an operating revenue of Rs. 15.41 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 74%, which is bit higher. It is currently FORMING a base in its weekly chart and is trading around 30% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 118 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 5 | 1 | 2 | 6 |
| Operating Expenses Qtr Cr | 4 | 1 | 2 | 6 |
| Operating Profit Qtr Cr | 1 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 |
Vivanza Biosciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 151.73
- 50 Day
- 153.79
- 100 Day
- 151.18
- 200 Day
- 138.19
- 20 Day
- 152.45
- 50 Day
- 156.21
- 100 Day
- 159.75
- 200 Day
- 132.86
Vivanza Biosciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 146.9 |
| Second Resistance | 146.9 |
| Third Resistance | 146.9 |
| RSI | 45.21 |
| MFI | 42.2 |
| MACD Single Line | 0.75 |
| MACD | -0.57 |
| Support | |
|---|---|
| First Resistance | 146.9 |
| Second Resistance | 146.9 |
| Third Resistance | 146.9 |
Vivanza Biosciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 2,001 | 173,607 | 86.76 |
| Week | 1,002 | 88,475 | 88.32 |
| 1 Month | |||
| 6 Month | 64 | 5,616 | 87.16 |
Vivanza Biosciences Result Highlights
Vivanza Biosciences Synopsis
BSE-Medical-Diversified
Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 9.15 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2022. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.| Market Cap | 58 |
| Sales | 14 |
| Shares in Float | 0.21 |
| No of funds | 2 |
| Yield |
| Book Value | 15.24 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | |
| Alpha | -0.04 |
| Beta | 0.38 |
Vivanza Biosciences
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 47.8% | 47.8% | 47.8% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 5.67% | 5.67% | 5.67% | |
| Others | 46.53% | 46.53% | 46.53% |
Vivanza Biosciences Management
| Name | Designation |
|---|---|
| Mr. Parikh H A | Director |
| Ms. Patel M S | Director |
| Mr. Bhatt G B | Director |
| Mr. Shah S D | Director |
Vivanza Biosciences Forecast
Price Estimates
Vivanza Biosciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-01-24 | Quarterly Results & Stock Split | |
| 2022-11-11 | Quarterly Results | |
| 2022-07-21 | Quarterly Results | |
| 2022-06-21 | Preferential issue of shares | |
| 2022-06-15 | A.G.M. |
Vivanza Biosciences FAQs
What is Share Price of Vivanza Biosciences ?
Vivanza Biosciences share price is ₹145 As on 30 January, 2023 | 04:25
What is the Market Cap of Vivanza Biosciences ?
The Market Cap of Vivanza Biosciences is ₹58.3 Cr As on 30 January, 2023 | 04:25
What is the P/E ratio of Vivanza Biosciences ?
The P/E ratio of Vivanza Biosciences is 116.2 As on 30 January, 2023 | 04:25
What is the PB ratio of Vivanza Biosciences ?
The PB ratio of Vivanza Biosciences is 16.7 As on 30 January, 2023 | 04:25